Role of angiotensin - converting enzyme inhibitors in early antihypertensive treatment in non - insulin dependent diabetes mellitus . 
<br>
<br> The effect of captopril monotherapy on <font color="red">blood_1</font> <font color="red">pressure_1</font> and <font color="red">metabolism_1</font> was investigated in a placebo - controlled study in 30 non - insulin dependent ( Type II ) diabetic subjects during a 3-week observation period ( run - in / drug ; placebo / wash - out ) on a metabolic ward . Captopril significantly reduced both <font color="red">systolic_1</font> <font color="red">and_1</font> <font color="red">diastolic_1</font> <font color="red">blood_1</font> <font color="red">pressure_1</font> ( 154/90 + /- 5/2 vs. 144/86 + /- 4/3 mmHg ) without <font color="red">major_1</font> <font color="red">side_1</font> <font color="red">effects_1</font> <font color="red">._1</font> Mean run - in <font color="red">postprandial_1</font> <font color="red">blood_1</font> <font color="red">glucose_1</font> <font color="red">concentrations_1</font> were also reduced upon ACE - inhibition ( 9 a.m. : 12.7 + /- 0.4 vs. 11.1 + /- 0.4 mmol / l ; 1 p.m. : 11.0 + /- 0.3 vs. 8.9 + /- 0.3 mmol / l ; P less than 0.05 ) , while <font color="red">blood_1</font> <font color="red">kinin_1</font> <font color="red">concentrations_1</font> ( 40.0 + /- 2.5 pmol / l ) were approximately doubled ( 108.8 + /- 23.5 pmol / l ; P less than 0.05 ) . <font color="red">Body_1</font> <font color="red">mass_1</font> <font color="red">index_1</font> <font color="red">,_1</font> <font color="red">fasting_1</font> <font color="red">plasma_1</font> <font color="red">insulin_1</font> <font color="red">,_1</font> <font color="red">serum_1</font> <font color="red">electrolyte_1</font> <font color="red">pattern_1</font> <font color="red">,_1</font> <font color="red">uric_1</font> <font color="red">acid_1</font> <font color="red">,_1</font> <font color="red">white_1</font> <font color="red">blood_1</font> <font color="red">count_1</font> <font color="red">,_1</font> <font color="red">lipid_1</font> <font color="red">profile_1</font> as well as <font color="red">hepatic_1</font> <font color="red">and_1</font> <font color="red">renal_1</font> <font color="red">function_1</font> <font color="red">parameters_1</font> remained unaltered throughout the observation period . The data are in line with recent experimental studies showing a beneficial metabolic effect of captopril in Type II diabetes . ACE inhibitors might therefore become first - line drugs in early antihypertensive intervention in Type II diabetic patients .